Author(s):
Tina Raju, Swathy Lakshmi N, Jisha Prems, Lal Prasanth ML
Email(s):
wajidahmad806@gmail.com
DOI:
10.52711/0975-4377.2024.00056 
Address:
Tina Raju, Swathy Lakshmi N, Jisha Prems, Lal Prasanth ML
Dr. Moopen’s College of Pharmacy, Naseera Nagar, Meppadi P.O., Wayanad - 673577, Kerala, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2024
ABSTRACT:
The covid-19 pandemic has made a profound impact on the mental and physical well-being of people worldwide. Apart from just treatment and prevention of such diseases which keep on emerging through mutation, it is also necessary to focus on mental health of patients. An emerging trend in this regard is psychobiotics. These are defined as probiotics that impart mental health comfort to the host when consumed in a particular quantity through the interaction with commensal gut bacteria. Depression and anxiety are disorders with greater number of cases worldwide. Although there are many treatment strategies, undesirable effects are seen. The highlight of this review is to spotlight on importance of psychobiotics in maintaining psychiatric health and its correlation with gut microbiota. It also includes different proposed mechanism and researches conducted so far to ascertain its value to human kind. Researches on psychobiotics which evidently prove that they should be considered and explored in detail have been showcased in this article. A few examples of fermented foods that exhibit psychobiotic potential along with dose have also been tabulated.
Cite this article:
Tina Raju, Swathy Lakshmi N, Jisha Prems, Lal Prasanth ML. Psychobiotics: An Emerging Solution for Alleviation of Psychotic Disorders. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):357-4. doi: 10.52711/0975-4377.2024.00056
Cite(Electronic):
Tina Raju, Swathy Lakshmi N, Jisha Prems, Lal Prasanth ML. Psychobiotics: An Emerging Solution for Alleviation of Psychotic Disorders. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):357-4. doi: 10.52711/0975-4377.2024.00056 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-4-10
REFERENCES:
1. Chisholm D., Sweeny K., Sheehan P., Rasmussen B., Smit F., Cuijpers P., Saxena S. Scaling-up treatment of depression and anxiety: A global return on investment analysis. Lancet Psychiatry. 2016; 3: 415–424.
2. Cohen B.E., Edmondson D., Kronish I.M. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am. J. Hypertens. 2015; 28: 1295–1302.
3. Wasilewski A., Zielińska M., Storr M., Fichna J. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease: Inflamm. Bowel Dis. 2015; 21: 1674–1682.
4. Carabotti M., Scirocco A., Maselli M.A., Severi C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015; 28: 203–209.
5. Cryan J.F., O’Mahony S.M. The microbiome-gut-brain axis: From bowel to behavior: From bowel to behavior. Neurogastroenterol. Motil. 2011; 23: 187–192.
6. Foster J.A., McVey Neufeld K.-A. Gut–brain axis: How the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36: 305–312.
7. Sarkar A., Lehto S.M., Harty S., Dinan T.G., Cryan J.F., Burnet P.W.J. Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals. Trends Neurosci. 2016; 39: 763–781.
8. Lou De Santis G., Kavvadia M., Abd Almajeed Abbaas Alwardat N., Bigioni G., Zeppieri C., Cascapera S., De Lorenzo A. Psychobiotics as integrative therapy for neuropsychiatric disorders with special emphasis on the microbiota-gut-brain axis. Biomed. Prev. Issues. 2017; 2: 111.
9. Vaghef-Mehrabany E., Maleki V., Behrooz M., Ranjbar F., Ebrahimi-Mameghani M. Can psychobiotics “mood” ify gut? An update systematic review of randomized controlled trials in healthy and clinical subjects, on anti-depressant effects of probiotics, prebiotics, and synbiotics. Clin. Nutr. 2020; 39: 1395–1410.
10. Farzi A., Fröhlich E.E., Holzer P. Gut Microbiota and the Neuroendocrine System. Neurotherapeutics. 2018; 15: 5–22.
11. Ait-Belgnaoui A., Colom A., Braniste V., Ramalho L., Marrot A., Cartier C., Houdeau E., Theodorou V., Tompkins T. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 2014; 26: 510–520.
12. Schirmer M., Smeekens S.P., Vlamakis H., Jaeger M., Oosting M., Franzosa E.A., ter Horst R., Jansen T., Jacobs L., Bonder M.J., et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016; 167: 1125–1136.
13. Rea K., Dinan T.G., Cryan J.F. The microbiome: A key regulator of stress and neuroinflammation. Neurobiol. Stress. 2016; 4: 23–33.
14. Erny D., de Hrabě Angelis A.L., Jaitin D., Wieghofer P., Staszewski O., David E., Keren-Shaul H., Mahlakoiv T., Jakobshagen K., Buch T., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 2015; 18: 965–977.
15. Hooper L.V. Interactions between the microbiota and the immune system. Science. 2012; 336: 1268–1273.
16. Turnbaugh P.J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027–1031.
17. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA. 2011; 108: 16050–16055.
18. Pinto-Sanchez M.I., Hall G.B., Ghajar K., Nardelli A., Bolino C., Lau J.T., Martin F.-P., Cominetti O., Welsh C., Rieder A., et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients with Irritable Bowel Syndrome. Gastroenterology. 2017; 153: 448–459.
19. Kantak P.A., Bobrow D.N., Nyby J.G. Obsessive–compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG) Behav. Pharmacol. 2014; 25: 71–79.
20. Dinan T.G. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry. 2013; 74: 720–726.
21. Chung Y.-C., Jin H.-M., Cui Y., Kim D.S., Jung J.M., Park J.-I., Jung E.-S., Choi E.-K., Chae S.-W. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods. 2014; 10: 465–474.
22. Kato-Kataoka A., Nishida K., Takada M., Suda K., Kawai M., Shimizu K., Kushiro A., Hoshi R., Watanabe O., Igarashi T., et al. Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Benef. Microbes. 2016; 7: 153–156. doi: 10.3920/BM2015.0100.
23. Takada M., Nishida K., Kataoka-Kato A., Gondo Y., Ishikawa H., Suda K., Kawai M., Hoshi R., Watanabe O., Igarashi T., et al. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut–brain interaction in human and animal models. Neurogastroenterol. Motil. 2016; 28: 1027–1036.
24. Mayer E.A. Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 2014; 34: 15490–15496.
25. Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010; 170: 1179–1188.
26. Nishida K., Sawada D., Kawai T., Kuwano Y., Fujiwara S., Rokutan K. Para-psychobiotic Lactobacillus gasseri CP 2305 ameliorates stress-related symptoms and sleep quality. J. Appl. Microbiol. 2017; 123: 1561–1570.